These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
332 related articles for article (PubMed ID: 28534160)
21. Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis. Urban D; Pöss J; Böhm M; Laufs U J Am Coll Cardiol; 2013 Oct; 62(16):1401-8. PubMed ID: 23973703 [TBL] [Abstract][Full Text] [Related]
22. Genetic spectrum of low density lipoprotein receptor gene variations in South Indian population. ArulJothi KN; Suruthi Abirami B; Devi A Clin Chim Acta; 2018 Mar; 478():28-36. PubMed ID: 29269200 [TBL] [Abstract][Full Text] [Related]
23. Genetic associations between serum low LDL-cholesterol levels and variants in LDLR, APOB, PCSK9 and LDLRAP1 in African populations. Hayat M; Kerr R; Bentley AR; Rotimi CN; Raal FJ; Ramsay M PLoS One; 2020; 15(2):e0229098. PubMed ID: 32084179 [TBL] [Abstract][Full Text] [Related]
24. Whole-Gene Duplication of PCSK9 as a Novel Genetic Mechanism for Severe Familial Hypercholesterolemia. Iacocca MA; Wang J; Sarkar S; Dron JS; Lagace T; McIntyre AD; Lau P; Robinson JF; Yang P; Knoll JH; Cao H; McPherson R; Hegele RA Can J Cardiol; 2018 Oct; 34(10):1316-1324. PubMed ID: 30269829 [TBL] [Abstract][Full Text] [Related]
25. A combined LDL receptor/LDL receptor adaptor protein 1 mutation as the cause for severe familial hypercholesterolemia. Soufi M; Rust S; Walter M; Schaefer JR Gene; 2013 May; 521(1):200-3. PubMed ID: 23510778 [TBL] [Abstract][Full Text] [Related]
26. Removal of plasma mature and furin-cleaved proprotein convertase subtilisin/kexin 9 by low-density lipoprotein-apheresis in familial hypercholesterolemia: development and application of a new assay for PCSK9. Hori M; Ishihara M; Yuasa Y; Makino H; Yanagi K; Tamanaha T; Kishimoto I; Kujiraoka T; Hattori H; Harada-Shiba M J Clin Endocrinol Metab; 2015 Jan; 100(1):E41-9. PubMed ID: 25313916 [TBL] [Abstract][Full Text] [Related]
27. Genetic and molecular architecture of familial hypercholesterolemia. Abifadel M; Boileau C J Intern Med; 2023 Feb; 293(2):144-165. PubMed ID: 36196022 [TBL] [Abstract][Full Text] [Related]
28. Widening the spectrum of genetic testing in familial hypercholesterolaemia: Will it translate into better patient and population outcomes? Page MM; Bell DA; Watts GF Clin Genet; 2020 Apr; 97(4):543-555. PubMed ID: 31833051 [TBL] [Abstract][Full Text] [Related]
29. Shifting the LDL-receptor paradigm in familial hypercholesterolemia: novel insights from recent kinetic studies of apolipoprotein B-100 metabolism. Barrett PH; Watts GF Atheroscler Suppl; 2002 Mar; 2(3):1-4. PubMed ID: 11923121 [TBL] [Abstract][Full Text] [Related]
30. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Robinson JG J Manag Care Pharm; 2013 Mar; 19(2):139-49. PubMed ID: 23461430 [TBL] [Abstract][Full Text] [Related]